Gelberg Kitty H, El-Bassel Nabila, Babineau Denise C, Vickers-Smith Rachel A, Fanucchi Laura C, Childerhose Janet E, Hall Megan E, Dzurec Megan E, Villani Jennifer, Russo Mary R, LeBaron Patricia, Marks Katherine R, Lancaster Kathyrn E, Gilbert Louisa, David James L, Eggleston Barry S, Roeber Carter A, Oga Emmanuel A, Chandler Redonna K, Walsh Sharon L
Columbia University, School of Social Work, 1255 Amsterdam Ave, NY, NY 10027, United States.
Columbia University, School of Social Work, 1255 Amsterdam Ave, NY, NY 10027, United States.
Int J Drug Policy. 2025 Jun 9;143:104867. doi: 10.1016/j.drugpo.2025.104867.
The Stay Safe Study, conducted between May and December 2023 in the United States, investigated the association between fentanyl test strip (FTS) use and risk reduction behaviors. This paper examines the association between self-reported FTS results and change in drug use behaviors.
We solicited self-reported drug and FTS use among people who use drugs (PWUD), with a baseline and four weekly surveys over a 28-day observation period in three states (Kentucky, New York and Ohio). For each day participants reported drug use, they were asked types of drugs used, use of FTS, FTS results, and 12 drug use behavior changes because of the result. A generalized estimating equation approach was used to model associations between FTS results and each outcome.
These analyses included 541 PWUD who used FTS at least once in the observation period. Positive FTS results were associated with participants taking turns, having naloxone nearby, and using less drugs. There was a four-fold reduction in the amount of drugs used following a positive FTS result (odds ratio (OR)=4.37; 95 % CI, 3.45-5.55). This was modified by self-reported types of drugs tested, with a 20-fold reduction when testing illicit benzodiazepines (OR=19.92; 95 % CI, 8.6-46.27), a 10-fold reduction when testing illicit stimulants (OR=10.04; 95 % CI, 6.49-15.53), and 2-fold reduction in drugs used when testing illicit opioids or other drugs tested (OR=2.11; 95 % CI, 1.14-3.92).
These findings suggest that FTS assist PWUD to immediately reduce their risks by changing drug use behaviors, including reducing the amount of drug used.
2023年5月至12月在美国进行的“安全停留研究”调查了芬太尼检测试纸(FTS)的使用与风险降低行为之间的关联。本文研究了自我报告的FTS结果与药物使用行为变化之间的关联。
我们在三个州(肯塔基州、纽约州和俄亥俄州)对吸毒者(PWUD)进行了自我报告的药物和FTS使用情况调查,在28天的观察期内进行了一次基线调查和四次每周调查。对于参与者报告吸毒的每一天,他们被问及使用的毒品类型、FTS的使用情况、FTS结果,以及由于结果导致的12种药物使用行为变化。采用广义估计方程方法对FTS结果与每个结果之间的关联进行建模。
这些分析包括541名在观察期内至少使用过一次FTS的PWUD。FTS阳性结果与参与者轮流使用、身边有纳洛酮以及减少药物使用有关。FTS结果呈阳性后,使用的药物量减少了四倍(优势比(OR)=4.37;95%置信区间,3.45-5.55)。这因自我报告的检测毒品类型而有所不同,检测非法苯二氮䓬类药物时减少了20倍(OR=19.92;95%置信区间,8.6-46.27),检测非法兴奋剂时减少了10倍(OR=10.04;95%置信区间,6.49-15.53),检测非法阿片类药物或其他检测药物时使用的药物减少了2倍(OR=2.11;95%置信区间,1.14-3.92)。
这些发现表明,FTS通过改变药物使用行为,包括减少药物使用量,帮助PWUD立即降低风险。